USP15 and lung adenocarcinoma: In relation to our data for A549 cells, we examined the provisional TCGA data set for lung adenocarcinoma and found that USP15 is altered in 30 of 230 cases (13%), most commonly being amplified and/or overexpressed (Fig. 9a).